Literature DB >> 9832685

Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection.

M Okada1, N Tsubota, M Yoshimura, Y Miyamoto.   

Abstract

OBJECTIVE: The aims of this study were to reveal the characteristics of skipping N2 lung cancer and to develop a more reasonable approach for dissecting mediastinal lymph nodes.
METHODS: Of consecutive 956 patients who were operated on for primary lung cancer from 1986 through 1996, 760 (79.5%) had a diagnosis of non-small cell carcinoma and were subjected to complete resection of the tumor together with hilar and mediastinal lymphadenectomy.
RESULTS: Of 141 patients with N2 disease, 53 (37.6%) had skipping metastases. Among 78 patients with N2 cancer of the upper lobe, 37 (47.4%) had skipping metastases affecting upper or aortic mediastinal nodes whereas none of them had skipping metastases affecting lower mediastinal nodes. Among 47 patients with N2 cancer of the lower lobe, 13 (27.7%) had skipping metastases affecting mediastinal nodes. Of these 13 patients, 11 (84.6%) had skipping metastases affecting the subcarinal node. The remaining 2 patients had a huge primary tumor.
CONCLUSIONS: Dissection of the upper part of the mediastinum including the aortic regions should be performed regardless of the operative appearance when cancer is located in the upper lobe, but it is not required for lower lobe tumors with negative hilar and subcarinal nodes. Dissection of the subcarinal node in patients with an upper lobe tumor is not routinely needed when the nodes in both the hilum and upper mediastinum are intact. We consider that the subcarinal node is of significance and skipping metastases should be defined as metastases that skip the subcarinal node in addition to N1 nodes.

Entities:  

Mesh:

Year:  1998        PMID: 9832685     DOI: 10.1016/S0022-5223(98)70045-5

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  28 in total

1.  Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients.

Authors:  Shinichiro Miyoshi; Kazuhiko Shien; Shinichi Toyooka; Kentaroh Miyoshi; Hiromasa Yamamoto; Seiichiro Sugimoto; Junichi Soh; Makio Hayama; Masaomi Yamane; Takahiro Oto
Journal:  Surg Today       Date:  2013-10-31       Impact factor: 2.549

2.  Has lobe-specific nodal dissection for early-stage non-small lung cancer already become standard treatment?

Authors:  Tomohiro Maniwa; Ken Kodama
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  Selective mediastinal lymphadenectomy without intraoperative frozen section examinations for clinical stage I non-small-cell lung cancer: retrospective study of 403 cases.

Authors:  Wei Jiang; Xiaoke Chen; Junjie Xi; Qun Wang
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

4.  A lobe-specific lymphadenectomy protocol for solitary pulmonary nodules in non-small cell lung cancer.

Authors:  Xue-Ning Yang; Ze-Rui Zhao; Wen-Zhao Zhong; Qiang Nie; Ri-Qiang Liao; Song Dong
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

Review 5.  Selective lymph node dissection in early-stage non-small cell lung cancer.

Authors:  Han Han; Haiquan Chen
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  Mediastinal lymph node dissection in surgical treatment for early stage non-small-cell lung cancer: lobe-specific or systematic?

Authors:  Hiroyuki Adachi; Takamitsu Maehara; Haruhiko Nakayama; Munetaka Masuda
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 7.  Mediastinal lymph nodes: ignore? sample? dissect? The role of mediastinal node dissection in the surgical management of primary lung cancer.

Authors:  Jean Deslauriers
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-08-09

8.  Analysis of the risk factors of postoperative cardiopulmonary complications and ability to predicate the risk in patients after lung cancer surgery.

Authors:  Yue Li; Yin-Lu Ma; Yong-Yin Gao; Dan-Dan Wang; Qing Chen
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

9.  Postoperative complications in elderly patients after lung cancer surgery.

Authors:  Satoshi Shiono; Masami Abiko; Toru Sato
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-20

10.  Analysis of factors influencing skip lymphatic metastasis in pN(2) non-small cell lung cancer.

Authors:  Gui-Long Li; Yong Zhu; Wei Zheng; Chao-Hui Guo; Chun Chen
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.